Arrivent BioPharma, Inc. (AVBP)
16.56
+0.10
(+0.61%)
USD |
NASDAQ |
Oct 13, 12:33
Arrivent BioPharma Price to Book Value : 2.181 for Oct. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 2.168 |
| October 09, 2026 | 2.204 |
| October 08, 2026 | 2.201 |
| October 07, 2026 | 2.225 |
| October 06, 2026 | 1.988 |
| October 05, 2026 | 3.749 |
| October 02, 2026 | 3.724 |
| October 01, 2026 | 3.811 |
| September 30, 2026 | 3.988 |
| September 29, 2026 | 3.891 |
| September 28, 2026 | 3.859 |
| September 25, 2026 | 3.747 |
| September 24, 2026 | 3.965 |
| September 23, 2026 | 3.991 |
| September 22, 2026 | 3.994 |
| September 21, 2026 | 3.917 |
| September 18, 2026 | 3.807 |
| September 17, 2026 | 3.736 |
| September 16, 2026 | 3.642 |
| September 15, 2026 | 3.684 |
| September 14, 2026 | 3.763 |
| September 11, 2026 | 3.820 |
| September 10, 2026 | 3.780 |
| September 09, 2026 | 3.924 |
| September 08, 2026 | 3.988 |
| Date | Value |
|---|---|
| September 04, 2026 | 4.077 |
| September 03, 2026 | 4.087 |
| September 02, 2026 | 4.019 |
| September 01, 2026 | 3.971 |
| August 31, 2026 | 3.958 |
| August 28, 2026 | 3.974 |
| August 27, 2026 | 4.083 |
| August 26, 2026 | 4.102 |
| August 25, 2026 | 4.129 |
| August 24, 2026 | 3.722 |
| August 21, 2026 | 3.836 |
| August 20, 2026 | 3.844 |
| August 19, 2026 | 3.954 |
| August 18, 2026 | 3.952 |
| August 17, 2026 | 3.821 |
| August 14, 2026 | 3.887 |
| August 13, 2026 | 3.952 |
| August 12, 2026 | 4.144 |
| August 11, 2026 | 4.135 |
| August 10, 2026 | 4.082 |
| August 07, 2026 | 4.062 |
| August 06, 2026 | 4.085 |
| August 05, 2026 | 4.032 |
| August 04, 2026 | 4.148 |
| August 03, 2026 | 3.904 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.453 |
| Alnylam Pharmaceuticals, Inc. | 21.93 |
| Anika Therapeutics, Inc. | 2.008 |
| Savara, Inc. | 6.913 |
| Vericel Corp. | 5.609 |
Price to Book Value Related Metrics
| Price | 16.56 |
| Earnings Yield | -22.23% |
| Market Cap | 800.17M |